These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2962885)

  • 21. Age-dependent changes in rat hepatic fructose 2, 6-bisphosphate, 6-phosphofructo-2-kinase/fructose 2, 6-bisphosphatase and pyruvate kinase activity in response to a high protein diet or starvation.
    Chanez M; Bois-Joyeux B; Peret J
    Diabete Metab; 1988; 14(2):80-7. PubMed ID: 2841176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and expression in Escherichia coli of a rat hepatoma cell cDNA coding for 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Crepin KM; Darville MI; Michel A; Hue L; Rousseau GG
    Biochem J; 1989 Nov; 264(1):151-60. PubMed ID: 2557826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of distinct mRNAs coding for putative isozymes of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Crepin KM; Darville MI; Hue L; Rousseau GG
    Eur J Biochem; 1989 Aug; 183(2):433-40. PubMed ID: 2547611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of 6-phosphofructo-2-kinase activity by cyclic AMP-dependent phosphorylation.
    el-Maghrabi MR; Claus TH; Pilkis J; Pilkis SJ
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):315-9. PubMed ID: 6281762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A stabilizing factor for liver phosphofructokinase.
    Dunaway GA; Segal HL
    Biochem Biophys Res Commun; 1974 Feb; 56(3):689-96. PubMed ID: 4275026
    [No Abstract]   [Full Text] [Related]  

  • 26. Tolbutamide inhibits cAMP-dependent phosphorylation of liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Aoki M; Kaku K; Inoue H; Matsutani A; Kaneko T
    Diabetes; 1992 Mar; 41(3):334-8. PubMed ID: 1312965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity and kinetics of liver 6-phosphofructokinase in normal and diabetic rats.
    Marynissen G; Sener A; Malaisse WJ
    Diabetes Res; 1989 Nov; 12(3):117-22. PubMed ID: 2534526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The primary structure of human liver type phosphofructokinase and its comparison with other types of PFK.
    Levanon D; Danciger E; Dafni N; Bernstein Y; Elson A; Moens W; Brandeis M; Groner Y
    DNA; 1989 Dec; 8(10):733-43. PubMed ID: 2533063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse.
    Da Silva D; Zancan P; Coelho WS; Gomez LS; Sola-Penna M
    Arch Biochem Biophys; 2010 Apr; 496(1):53-60. PubMed ID: 20117072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of 6-phosphofructo-1-kinase subunit protein, synthesis rates, and mRNA during rat neonatal development.
    Mhaskar Y; Dunaway GA
    Mech Ageing Dev; 1996 Mar; 86(3):161-72. PubMed ID: 8733111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of 6-phosphofructo-2-kinase from foetal-rat liver.
    Martín-Sanz P; Cascales M; Boscá L
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):457-63. PubMed ID: 1310598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of expression of phosphofructokinase isoforms in isolated rat pancreatic islets and purified beta cells and cloning and expression of the rat phosphofructokinase-A isoform.
    Ma Z; Ramanadham S; Kempe K; Hu Z; Ladenson J; Turk J
    Biochim Biophys Acta; 1996 Aug; 1308(2):151-63. PubMed ID: 8764833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The subunit proportions and kinetic properties of 6-phosphofructo-1-kinase isozymes from rat heart atria and ventricle progressively change during aging.
    Mhaskar Y; Dunaway GA
    Mol Cell Biochem; 1991 Sep; 107(1):39-45. PubMed ID: 1838402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation by insulin of glycolysis in cultured hepatocytes is attenuated by extracellular ATP and puromycin through purine-dependent inhibition of phosphofructokinase 2 activation.
    Probst I; Quentmeier A; Schweickhardt C; Unthan-Fechner K
    Eur J Biochem; 1989 Jun; 182(2):387-93. PubMed ID: 2525468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-bisphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cells.
    Ceppi ED; Knowles RG; Carpenter KM; Titheradge MA
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):761-6. PubMed ID: 1320377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are the rat tissue/organ proportions of 6-phosphofructo-1-kinase subunits strain-specific?
    Dunaway GA; Kasten T
    Biochem J; 1986 Jul; 237(1):157-61. PubMed ID: 2948488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of skeletal muscle 6-phosphofructo-1-kinase during aging and development.
    Dunaway GA; Kasten TP; Nickols GA; Chesky JA
    Mech Ageing Dev; 1986 Sep; 36(1):13-23. PubMed ID: 2945061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and pyruvate kinase by cyclic adenosine 3',5'-monophosphate in fetal and adult hepatocytes.
    Casado M; Boscá L; Martín-Sanz P
    J Cell Physiol; 1995 Dec; 165(3):630-8. PubMed ID: 7593243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of PFK subunit protein, synthesis, and mRNA during neonatal brain development.
    Mhaskar Y; Dunaway GA
    Brain Res Dev Brain Res; 1995 Mar; 85(1):54-7. PubMed ID: 7781167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic AMP-dependent phosphorylation of rat liver 6-phosphofructo 2-kinase, fructose 2,6-bisphosphatase.
    El-Maghrabi MR; Fox E; Pilkis J; Pilkis SJ
    Biochem Biophys Res Commun; 1982 Jun; 106(3):794-802. PubMed ID: 6288034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.